» Articles » PMID: 26512274

Primary Spinal Cord Oligodendroglioma with Postoperative Adjuvant Radiotherapy: A Case Report

Overview
Journal Korean J Spine
Date 2015 Oct 30
PMID 26512274
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Primary spinal cord oligodendrogliomas are rare tumors comprising two percent of all spinal cord tumors. Although a treatment guideline has yet to be established, maximal surgical resection is primary in the treatment of spinal cord oligodendrogliomas. Adjuvant radiotherapy has remained controversial, and it is unclear whether chemotherapy adds any benefit. In this case report, the authors present a 24-year-old male who had a seven-year history of left leg weakness and a radiating pain in both legs. Magnetic resonance image (MRI) showed an intramedullary mass at the T4-T8 level. He underwent subtotal removal of the tumor and pathologic diagnosis revealed a WHO grade II oligodendroglioma. The patient was treated with radiotherapy postoperatively and followed up with MRI annually. Clinical and radiological status of the patient had been stationary for four years after the surgery. The five-year follow-up MRI showed an increase in the size and extent of the residual tumor. Despite radiological progression, considering that symptoms and the performance status of the patient had remained unchanged, further treatment has not been performed. Given the clinical outcome of this patient, close observation after subtotal removal with adjuvant radiotherapy is one of the acceptable treatment options for WHO grade II spinal cord oligodendrogliomas.

Citing Articles

A rare case of primary spinal cord oligodendroglioma.

Eppy Buchori Aristiady K, Ellya Radiol Case Rep. 2023; 18(6):2303-2306.

PMID: 37153481 PMC: 10159816. DOI: 10.1016/j.radcr.2023.03.050.


A very rare spinal cord tumor primary spinal oligodendroglioma: A review of sixty cases in the literature.

Hasturk A, Gokce E, Elbir C, Gel G, Canbay S J Craniovertebr Junction Spine. 2017; 8(3):253-262.

PMID: 29021677 PMC: 5634112. DOI: 10.4103/jcvjs.JCVJS_1_17.

References
1.
Wang F, Qiao G, Lou X . Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide. J Neurooncol. 2010; 104(1):387-94. DOI: 10.1007/s11060-010-0493-1. View

2.
Guppy K, Akins P, Moes G, Prados M . Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis. J Neurosurg Spine. 2009; 10(6):557-63. DOI: 10.3171/2009.2.SPINE08853. View

3.
Lundar T, Due-Tonnessen B, Egge A, Scheie D, Stensvold E, Brandal P . Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients. J Neurosurg Pediatr. 2013; 12(3):241-6. DOI: 10.3171/2013.6.PEDS12586. View

4.
Fountas K, Karampelas I, Nikolakakos L, Troup E, Robinson J . Primary spinal cord oligodendroglioma: case report and review of the literature. Childs Nerv Syst. 2004; 21(2):171-5. DOI: 10.1007/s00381-004-0973-8. View

5.
Shaw E, Arusell R, Scheithauer B, OFallon J, ONeill B, Dinapoli R . Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002; 20(9):2267-76. DOI: 10.1200/JCO.2002.09.126. View